Press Releases 2013

Boston Scientific Concludes Enrollment In Randomized, Multicenter, Pivotal Study Of SYNERGY™ Coronary Stent System - Sep 12, 2013

In a significant milestone toward obtaining additional key regulatory approvals for the SYNERGY™ Stent System, Boston Scientific Corporation (NYSE: BSX) has completed enrollment...

Read more

Boston Scientific Promus PREMIER™ And SYNERGY™ Drug-Eluting Stent Systems Provide Exceptional Safety And Efficacy Data - May 22, 2013

Boston Scientific Corporation (NYSE: BSX) reports positive results from two trials evaluating new, innovative drug-eluting stent (DES) technologies, which are emerging treatment...

Read more

Boston Scientific Schedule of Major Events and Presentations at EuroPCR 2013 - May 17, 2013

Boston Scientific Corporation (NYSE:BSX) is scheduled to participate at the annual EuroPCR Scientific Program May 21-24 in Paris.

Read more

The Boston Scientific PROMUS Element™ Platinum Chromium Stent Demonstrates Continued Low Event Rates Through Three Years - Mar 10, 2013

Separate Study Demonstrates PROMUS Element Stent has Significantly Less Vessel Straightening than the Xience V® Stent.

Read more

Promus PREMIER™ Everolimus-Eluting Platinum Chromium Stent System Receives CE Mark Approval - Feb 12, 2013

The Next Advance in Durable Polymer Stent Technology from Boston Scientific is Now Available in Europe and Other Select Geographies

Read more

Media Contacts

Rosie Ireland
Corporate Communications
+44 7585403359

Company Profile